Elevated PSA / Prostate Cancer Evaluation

A prostate-specific antigen (PSA) test measures a protein produced by the prostate gland. While PSA is often used as a screening tool for prostate cancer, an elevated PSA level does not automatically mean cancer.

Many common and non-cancerous conditions, such as an enlarged prostate (BPH), inflammation (prostatitis), or even recent physical activity, can also raise PSA levels. Because of this, PSA results must always be interpreted in context.

At The Medical Group of New Jersey, our urology specialists take a thoughtful, evidence-based approach to evaluating elevated PSA levels, focusing on accurate diagnosis, avoiding unnecessary procedures when possible, and ensuring that any serious condition is identified early and managed appropriately.

Symptom Onset & Initial Evaluation

Most patients with an elevated PSA have no symptoms at all. The finding is often discovered during routine screening or evaluation for other concerns.

In some cases, patients may also have urinary symptoms such as:

• Frequent urination or urgency
• Weak urine stream
• Difficulty starting urination
• Pelvic discomfort

These symptoms are more commonly related to BPH or prostatitis than prostate cancer, but they are still important to evaluate.

Evaluation

During your visit, your urologist will carefully review factors that can influence PSA levels.

This includes:

• Reviewing prior PSA results to assess trends over time
• Discussing recent activities (e.g., ejaculation, cycling) that may temporarily raise PSA
• Reviewing medications and supplements
• Assessing urinary symptoms and prostate health
• Discussing family history of prostate cancer
• Performing a digital rectal exam (DRE) to assess prostate size and texture

The goal is to determine whether the PSA elevation is likely benign or requires further evaluation.

Diagnosis & Risk Assessment

Evaluation of an elevated PSA is a stepwise process designed to balance early detection with avoidance of unnecessary procedures.

Repeat & Confirmatory Testing

• Repeat PSA testing: PSA levels may fluctuate, so repeating the test helps confirm whether the elevation is persistent
• Free vs. total PSA: Provides additional information about cancer risk in certain cases

Laboratory Testing (When Indicated)

• Urinalysis and urine culture: Rule out infection
• Inflammatory markers (in select cases): Evaluate for prostatitis

Imaging

• Multiparametric MRI of the prostate: Helps identify suspicious areas and guide biopsy decisions and is increasingly used to avoid unnecessary biopsies

Prostate Biopsy (If Indicated)

• Performed if imaging or PSA trends suggest higher risk
• May be targeted (MRI-guided) or systematic
• Provides definitive diagnosis

Risk Assessment

Your urologist will evaluate:

• PSA level and rate of change over time (PSA velocity)
• Age and overall health
• Family history (especially first-degree relatives)
• Race/ethnicity (certain populations have a higher risk)
• Findings on exam and imaging

This individualized risk assessment helps guide whether monitoring or further testing is appropriate.

Treatment & Management

Management depends on whether cancer is detected, and if so, how aggressive it appears.

If No Cancer Is Found

• Active monitoring: Periodic PSA testing and follow-up visits
• Addressing underlying causes such as BPH or prostatitis
• Avoiding unnecessary procedures when the risk is low

If Prostate Cancer Is Diagnosed

Treatment is highly individualized based on cancer risk level and patient preferences.

Active Surveillance (Low-Risk Cancer)

• Regular PSA testing, imaging, and occasional biopsy
• Avoids overtreatment while maintaining close monitoring

Definitive Treatment Options (When Needed)

• Surgery (prostatectomy): Removal of the prostate
• Radiation therapy: External beam or brachytherapy
• Hormonal therapy: For more advanced or aggressive disease

Your care team will clearly explain all options and help guide shared decision-making.

Monitoring & Follow-Up

Ongoing follow-up is essential, regardless of whether cancer is present.

Your urologist may recommend:

• Regular PSA testing to monitor trends
• Repeat imaging when indicated
• Follow-up exams and symptom review
• Long-term monitoring for patients on active surveillance

This structured approach ensures early detection of any changes while minimizing unnecessary interventions.

Prognosis & Preventive Care

When detected early, prostate cancer is highly treatable, and many patients have excellent long-term outcomes. Equally important, many patients with elevated PSA do not have cancer and can be safely monitored.

At The Medical Group of New Jersey, we emphasize clear communication, individualized care, and shared decision-making, ensuring that patients feel informed, supported, and confident throughout the evaluation process.